Skip to main content

Clinical Proteomics

  • Chapter
Molecular Genetic Pathology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested reading

Body Fluid Proteomics

  • Anderson NL, Anderson NG. The human plasma proteome: history character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845–867.

    Article  CAS  PubMed  Google Scholar 

  • Deutsch EW, Eng JK, Zhang H, et al. Human Plasma PeptideAtlas. Proteomics 2005;5:3497–3500.

    Article  CAS  PubMed  Google Scholar 

  • Lowenthal MS, Mehta AI, Frogale K, et al. Analysis of albuminassociated peptides and proteins from ovarian cancer patients. Clin Chem. 2005;51:1933–1945.

    Article  CAS  PubMed  Google Scholar 

  • Mehta AI, Ross S, Lowenthal MS, et al. Biomarker amplification by serum carrier protein binding. Dis Markers 2003;19:1–10.

    CAS  PubMed  Google Scholar 

  • Rosenblatt KP, Bryant-Greenwood P, Killian JK, et al. Serum proteomics in cancer diagnosis and management. Annu Rev Med. 2004;55:97–112.

    Article  CAS  PubMed  Google Scholar 

Clinical Proteomics

  • Celis JE, Gromov P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003;3:9–15.

    Article  CAS  PubMed  Google Scholar 

  • Liotta LA, Kohn EC, Petricoin EF. Clinical proteomics: personalized molecular medicine. JAMA 2001;286:2211–2214.

    Article  CAS  PubMed  Google Scholar 

  • Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov. 2002;1:683–695.

    Article  CAS  PubMed  Google Scholar 

  • Wulfkuhle JD, McLean KC, Paweletz CP, et al. New approaches to proteomic analysis of breast cancer. Proteomics 2001;1:1205–1215.

    Article  CAS  PubMed  Google Scholar 

Direct Tissue Mass Spectrometry

  • Chaurand P, Caprioli RM. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002;23:3125–3135.

    Article  CAS  PubMed  Google Scholar 

  • Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med. 2001;7:493–496.

    Article  CAS  PubMed  Google Scholar 

Laser Capture Microdissection

  • Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998–1001.

    Article  CAS  PubMed  Google Scholar 

Mass Spectrometry

  • Gygi SP, Aebersold R. Mass spectrometry and proteomics. Curr Opin Chem Biol. 2000;4:489–494.

    Article  CAS  PubMed  Google Scholar 

  • Hillenkamp F, Karas M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol. 1990;193:280–295.

    Article  CAS  PubMed  Google Scholar 

Protein Microarrays

  • Grubb RL, Calvert VS, Wulkuhle JD, et al. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003;3:2142–2146.

    Article  CAS  PubMed  Google Scholar 

  • Gulmann C, Espina V, Petricoin E, et al. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res. 2005;11:5847–5855.

    Article  CAS  PubMed  Google Scholar 

  • Herrmann PC, Gillespie JW, Charboneau L, et al. Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 2003;3:1801–1810.

    Article  CAS  PubMed  Google Scholar 

  • Knezevic V, Leethanakul C, Bichsel VE, et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001;1:1271–1278.

    Article  CAS  PubMed  Google Scholar 

  • Liotta LA, Espina V, Mehta AI, et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003;3:317–325.

    Article  CAS  PubMed  Google Scholar 

  • MacBeath G. Protein microarrays and proteomics. Nat Genet. Suppl 2002;32:526–532.

    Article  CAS  PubMed  Google Scholar 

  • Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of prosurvival pathways at the cancer invasion front. Oncogene 2001;20:1981–1989.

    Article  CAS  PubMed  Google Scholar 

Tumor Microenvironment

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Geho, D.H., Espina, V., Liotta, L.A., Petricoin, E.F., Wulfkuhle, J.D. (2008). Clinical Proteomics. In: Cheng, L., Zhang, D.Y. (eds) Molecular Genetic Pathology. Humana Press. https://doi.org/10.1007/978-1-59745-405-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-405-6_9

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-974-1

  • Online ISBN: 978-1-59745-405-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics